Add like
Add dislike
Add to saved papers

Effect of TiO 2 /Fe 2 O 3 nanopowder synthesis method on visible light photocatalytic degradation of reactive blue dye.

Heliyon 2024 April 31
Water pollution and scarcity of clean water are major issues of concern globally. In this study, titanium dioxide (TiO2 ) photocatalyst doped with ferric oxide (Fe2 O3 ) was used to degrade reactive blue dye (171) using sunlight irradiation. Two approaches were employed to synthesize the photocatalyst: synthesis of ferric oxide and titanium precursor through ultrasonic-assisted sol-gel method and using iron (III) nitrate nonahydrate with commercial titanium dioxide. The photocatalysts were characterized using FTIR Spectroscopy, SEM, XRD analyses, and UVDRS to determine their chemical composition, morphology, crystallinity, and light absorption, respectively. The effect of contaminant concentration (1-3 ppm), solution pH and photocatalyst type on the degradation efficiency was studied. Doping enabled visible light absorption as confirmed by the UVDRS analysis. Solar photocatalytic degradation resulted in complete (100 % removal) of the dye within 2 h under solar irradiation for all concentrations of the dye studied. Furthermore, the photocatalysts exhibited superior performance in both neutral and acidic solutions compared to basic ones. After four cycles, the dye removal efficiency has decreased by less than 15 % for all the photocatalysts confirming the significant activity and high stability of the nanocomposite. The increased dye photodegradation efficacy of Fe2 O3 doped TiO2 under sunlight irradiation is attributed to the narrowing of the photocatalyst's bandgap from 3.76 eV (in pure TiO2 ) to 2.83 eV. This narrowing of the bandgap enhances the absorption of visible light from sunlight, thus making this photocatalyst effective under sunlight and eliminating the use of electricity which is a requirement for ultraviolet photocatalysis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app